ロード中...
Access to new cancer medicines in Australia: dispelling the myths and informing a public debate
Despite the high level of spending on cancer medicines in Australia, consumer organisations and the pharmaceutical industry often make claims of delayed or lack of access to new cancer medicines—claims that are frequently supported by prominent coverage in the Australian media. These claims, while m...
保存先:
| 出版年: | J Pharm Policy Pract |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4823878/ https://ncbi.nlm.nih.gov/pubmed/27057313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-016-0062-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|